FDA.reportPublic FDA data

Application 211181

Type
ANDA
Sponsor
ELYSIUM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDETABLET;ORAL60MGNoNo
002PYRIDOSTIGMINE BROMIDEPYRIDOSTIGMINE BROMIDETABLET;ORAL30MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
58657-810Pyridostigmine BromidePYRIDOSTIGMINE BROMIDEMethod Pharmaceuticals, LLCANDACurrent
58657-810Pyridostigmine BromidePYRIDOSTIGMINE BROMIDEMethod Pharmaceuticals, LLCANDACurrent
58657-810Pyridostigmine BromidePYRIDOSTIGMINE BROMIDEMethod Pharmaceuticals, LLCANDACurrent
58657-810Pyridostigmine BromidePYRIDOSTIGMINE BROMIDEMethod Pharmaceuticals, LLCANDACurrent
60687-502Pyridostigmine BromidePyridostigmine BromideAmerican Health PackagingANDACurrent
60687-502Pyridostigmine BromidePyridostigmine BromideAmerican Health PackagingANDACurrent
60687-502Pyridostigmine BromidePyridostigmine BromideAmerican Health PackagingANDACurrent
63739-969Pyridostigmine BromidePyridostigmine BromideMcKesson Corporation dba SKY PackagingANDACurrent
63739-969Pyridostigmine BromidePyridostigmine BromideMcKesson Corporation dba SKY PackagingANDACurrent
65084-999Pyridostigmine BromidePyridostigmine BromideMcKesson Corporation dba RX PakANDACurrent
71930-028Pyridostigmine BromidePyridostigmine BromideEywa Pharma IncANDACurrent
71930-028Pyridostigmine BromidePyridostigmine BromideEywa Pharma IncANDACurrent